Results 171 to 180 of about 322,913 (349)
The article presents the results of researches of fatty aldehydes and total cholesterol of blood plasma of patients with multiple organ dysfunction syndrome.
A. N. Osipenko +2 more
doaj
Pannexin1: insight into inflammatory conditions and its potential involvement in multiple organ dysfunction syndrome. [PDF]
Chen X, Yuan S, Mi L, Long Y, He H.
europepmc +1 more source
Roles of calcium and IP3 in impaired colon contractility of rats following multiple organ dysfunction syndrome [PDF]
C. Zheyu, Qing-Hui Qi, Lünan Yan
openalex +1 more source
We developed a real‐time, label‐free, high‐throughput cell‐on‐a‐chip system based on a metasurface plasmon resonance colorimetric sensor (MetaSPRCS) to evaluate intestinal barrier function. This platform enables continuous monitoring of cell adhesion, proliferation, and barrier layer formation, disruption, and repair.
Youqian Chen +14 more
wiley +1 more source
Thyrotoxicosis Factitia Leading to Multiple Organ Dysfunction Syndrome [PDF]
V. Rayasam +4 more
openalex +1 more source
Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases
Mitochondrial transplantation (MTx) offers a promising therapeutic avenue for mitochondrial diseases. This review comprehensively evaluates MTx, differentiating its feasibility for mtDNA‐ and nDNA‐based disorders. It examines its potential for genetic correction, alongside inherent limitations, technical challenges, and crucial ethical considerations ...
Parmeshar Singh +17 more
wiley +1 more source
The Design of Nested Adaptive Clinical Trials of Multiple Organ Dysfunction Syndrome Children in a Single Study. [PDF]
VanBuren JM +7 more
europepmc +1 more source
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki +7 more
wiley +1 more source

